Short answer
MEDIFAST INC (MED) filed its Q1 2026 10-Q quarterly report on May 4, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $76M (down 34.3% year over year) with net income of −$2M.
Q1 2026 key financials · XBRL
- Revenue
- $76M
- −34.3% YoY
- Net income
- −$2M
- −174.9% YoY
- Operating margin
- -4.3%
- Gross margin
- 68.1%
- EPS (diluted)
- −$0.19
- −171.4% YoY
Source: XBRL data from the MEDIFAST INC (MED) Q1 2026 10-Q on SEC EDGAR. USD.
MEDIFAST INC Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $76.0M, down 34.3% YoY from $115.7M, driven by fewer active earning coaches
- Gross margin 68.1% vs 72.8% YoY; operating margin (4.3%) vs (1.1%)
- Active earning coaches 14,000 vs 25,400; revenue per coach $5,432 vs $4,556
- SG&A $55.1M, down 35.6% YoY, including $2.2M gain on Maryland distribution center sale
- Management expects active earning coaches to continue declining in 2026 amid GLP-1 adoption and client-acquisition pressure
Risk Factors
- No Risk Factors section provided; changes from the most recent 10-K cannot be assessed
- Repurchase-plan flexibility risk: Board may modify or terminate authorization without expiration date
- Market-execution risk: repurchases may vary by market conditions, timing, and prices
- Shareholder-engagement risk: Cooperation Agreement with Steamboat Capital Partners dated March 19, 2026
- Equity dilution risk: 84,498 shares surrendered for employee and director tax-withholding obligations at $9.63 per share
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other MEDIFAST INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.